文献库搜索 | GeneLibs

Hayano(Takahide),Matsui(Hiroshi),Nakaoka(H... PLoS One 0000-00-00

...BRCA2 and HOXB13. A comprehensive search of germline variants for patients with PC has not been reported in Japanese fam...

Lüder Ripoli(Florenza),Mohr(Annika),Conrad... Int J Mol Sci 0000-00-00

...BRCA2; BRCA1; HMGA2; and Her2) were analyzed via branched-DNA assay (b-DNA). ACTB, GAPDH, and HPRT1 were used as data no...

Koczkowska(Magdalena),Zuk(Monika),Gorczyns... Cancer Med 0000-00-00

...BRCA2) were identified. For 22 of 27 patients, nonneoplastic cells were available and sequencing revealed the somatic ch...

Fehringer(Gordon),Kraft(Peter),Pharoah(Pau... Cancer Res 0000-00-00

...BRCA2 locus with lung and serous ovarian cancer. This is the largest study to date examining pleiotropy across multiple ...

Childs(Erica J),Chaffee(Kari G),Gallinger(... Cancer Epidemiol Biomarkers... 0000-00-00

...BRCA2, PALB2, ATM, p16/CDKN2A or DNA mismatch repair genes), common genetic variants may also be involved. In a high-ris...

Brockway(J P),Carruthers(W B),Zapata(M),Re... J Clin Oncol 0000-00-00

...BRCA2 genes; family history of cancer; suspected of having recurrent cancer; anomalous mammogram/ultrasound; pain; or cl...

Tutt(A),Robson(M),Garber(J E),Domchek(S),A... J Clin Oncol 0000-00-00

...BRCA2 carriers with advanced refractory breast cancer. The secondary aim was to assess safety and tolerability in this p...

Scherr(Courtney Lynam),Bomboka(Linda),Nels... Patient Educ Couns 0000-00-00

...BRCA2 (BRCA) mutations, compared with other populations, that increases their risk for hereditary breast and ovarian can...

Yi(Joanna S),Kamihara(Junne),Kesselheim(Je... Pediatr Blood Cancer 0000-00-00

...BRCA2/FANCD1 mutations. Patient B, after SR B-precursor ALL induction therapy, was noted on fever workup to have a renal...

Michl(Johanna),Zimmer(Jutta),Buffa(Frances... Nat Struct Mol Biol 0000-00-00

The tumor suppressor BRCA2 plays a key role in genome integrity by promoting replication-fork stability and homologous r...